Barclays Maintains Underweight on Allstate, Lowers Price Target to $221
Barclays analyst Alex Scott maintains Allstate (NYSE:ALL) with a Underweight and lowers the price target from $226 to $221.
Share
Why It Matters
A big bank's expert thinks Allstate stock might not do as well as others. They lowered their price guess, so watch if the company keeps having trouble.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.